期刊文献+

强生干化学分析仪开放通道检测血清淀粉样蛋白A的性能验证 被引量:6

Performance Verification of the Measurement of Serum Amyloid A Using the Open Channel of Johnson Dry Chemistry Analyzer
下载PDF
导出
摘要 目的强生干化学分析仪开放通道搭载国产普瑞柏血清淀粉样蛋白A(serum amyloid A,SAA)试剂盒的分析性能验证。方法根据美国临床和实验室标准化协会(NCCLS)的检测仪器评价标准,并参照卫生部关于分析仪器的性能验证指南,对Vitros 5.1FS检测SAA的精密度、准确度、线性范围、最大稀释度和生物参考区间进行验证。结果 2个水平SAA批内及总精密度分别为S_(批内低)=0.3,S_(总低)=0.45和S_(批内高)=0.6,S_(总高)=1.01,均小于厂家声明的精密度。比对实验决定系数r^2=0.991 2,线性方程Y=0.962 9 X+0.204 6,其线性范围可以验证至5.99~92.59mg/L,最大稀释倍数可验证至10倍。23例健康个体中95.7%的个体SAA检测值处于厂家声明的参考区间之内。结论 Vitros 5.1FS搭载该SAA试剂盒的分析性能验证通过,该检测系统可以用于临床常规标本检测。 Objective To study the performance verification of serum amyloid A (SAA) using the open channel of Johnson dry chemistry analyzer. Methods According to CLSI instruments evaluation standards and referring to the NCCL perform- ance verification guides of the analytical instruments, the precision, accuracy,linear range, maximum dilution degree, biologi- cal reference range of the SAA detected by Vitros 5. 1 FS were verified. Results The intra-batch and total precision experiments were ;sl =0. 3, Stc=0. 45 and Sui=0.6, Stii=1. 01 respectively, and they were all under the statements of manufacturer. Compared with test r2=0.991 2,linear equation Y 0. 962 9X+0. 204 6,linearity range were reach 5.99~92.59 rag/ L,and the maximum dilution degree was 10 times. The SAA results of 95.7% of the 23 healthy individual were within the reference interval announced by the manufacturer. Conclusion Vitros 5. 1 FS and the SAA reagent have a good performance, this system can be used in routine tests in laboratory.
作者 黄迪 尚陈宇 万泽民 柯培锋 HUANG Di;SHANG Chen yu;WAN Ze min;KE Pei feng(Department of Clinical Laboratory,Guangdong Provincial Hospital of Chinese Medicine,Guangzhou 510120,China)
出处 《现代检验医学杂志》 CAS 2018年第5期137-141,共5页 Journal of Modern Laboratory Medicine
关键词 干化学 血清淀粉样蛋白A 性能验证 dry chemistry serum amyloicl A performance verification
  • 相关文献

参考文献6

二级参考文献61

  • 1宋琳,谭德明,方志雄.淀粉样蛋白a在治疗慢性丙型肝炎患者中的临床意义[J].中华临床感染病杂志,2008,1(2). 被引量:3
  • 2陈文祥,申子瑜,杨振华.临床检验分析质量指标的设定[J].中华检验医学杂志,2006,29(4):298-300. 被引量:51
  • 3Petersen HP, Fraser CG, Kallner A, et al. Introduction: strategies to set global quality specifications in laboratory medicine. Scand J Clin Lab Invest, 1999,59:477-478.
  • 4Fraser CG, Petersen HP, Ricos C, et al. Proposed quality specifications for the imprecision and inaccuracy of analytical systems in clinical chemistry. Eur J Clin Chem Clin Biochem, 1992,30:311-317.
  • 5Thienpont L,Franzini C, Kratochvila J, et al. Analytical quality specifications for reference methods and operating specifications for networks of reference laboratories. Eur J Clin Chem Clin Biochem, 1995,33:949-957.
  • 6Revere L,Blaek K. Integrating Six Sigma with total quality management: a case example for measuring medication errors. J Healthe Manag, 2003, 48:377-391.
  • 7Westgard JO, Carey RN, Wold S. Criteria for judging precision and accuracy in method development and evaluation. Clin Chem, 1974,20:825- 833.
  • 8Ehrmeyer SS, Laessig RH, Leinweber JE, et al. 1990 Medicare/CLIA final rules for proficiency testing: Minimum interlaboratory performance characteristics( CV and Bias) needed to pass. Clin Chem, 1990,36 : 1736-1740.
  • 9Westgard JO, Bumett RW. Precision requirements for cost-effective operation of analytical processes. Clin Chem, 1990,36 : 1629-1632.
  • 10Westgard JO. A method evaluation decision chart (MEDx Chart)for judging method performance. Clin Lab Science, 1995,8:277-283.

共引文献114

同被引文献43

引证文献6

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部